Emulation Differences vs. Biases When Calibrating Real-World Evidence Findings Against Randomized Controlled Trials

被引：35

作者：

Franklin, Jessica M. ^{[1
]}

Glynn, Robert J. ^{[1
]}

Suissa, Samy ^{[2
,3
,4
]}

Schneeweiss, Sebastian ^{[1
]}

机构：

[1] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA

[2] McGill Univ, Dept Epidemiol, Montreal, PQ, Canada

[3] McGill Univ, Dept Biostat, Montreal, PQ, Canada

[4] McGill Univ, Dept Occupat Hlth, Montreal, PQ, Canada

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2020年 / 107卷 / 04期

关键词：

D O I：

10.1002/cpt.1793

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Actionable real-world evidence (RWE) requires accurate estimation of causal treatment effects. Calibration of RWE against randomized controlled trials (RCTs) is sometimes done to demonstrate that RWE can support the same causal conclusion as RCTs. Disagreements can occur when studies in each pair asked different questions in different populations or due to the presence of residual bias. Distinguishing among reasons for differences will impact the level of confidence in RWE.

引用

页码：735 / 737

页数：3

共 50 条

[41] Randomized controlled trials and real-world evidence for the market access and surveillance of high-risk products-the example of paclitaxel
Behrendt, C-A
Rother, U.
Ruemenapf, G.
Uhl, C.
Goertz, H.
Boeckler, D.
GEFASSCHIRURGIE, 2021, 26 (02): : 110 - 117
[42] Generating real-world evidence compatible with evidence from randomized controlled trials: a novel observational study design applicable to surgical transfusion research
Yu, Xiaochu
Wang, Zixing
Wang, Lei
Huang, Yuguang
Wang, Yipeng
Xin, Shijie
Lei, Guanghua
Zhao, Shengxiu
Chen, Yali
Guo, Xiaobo
Han, Wei
Yu, Xuerong
Xue, Fang
Wu, Peng
Gu, Wentao
Jiang, Jingmei
BMC MEDICAL RESEARCH METHODOLOGY, 2022, 22 (01)
[43] Generating real-world evidence compatible with evidence from randomized controlled trials: a novel observational study design applicable to surgical transfusion research
Xiaochu Yu
Zixing Wang
Lei Wang
Yuguang Huang
Yipeng Wang
Shijie Xin
Guanghua Lei
Shengxiu Zhao
Yali Chen
Xiaobo Guo
Wei Han
Xuerong Yu
Fang Xue
Peng Wu
Wentao Gu
Jingmei Jiang
BMC Medical Research Methodology, 22
[44] Glargine-300: An updated literature review on randomized controlled trials and real-world studies
Ghosh, Sujoy
Ghosh, Romik
WORLD JOURNAL OF DIABETES, 2020, 11 (04) : 100 - 114
[45] Replication of Randomized, Controlled Trials Using Real-World Data: What Could Go Wrong?
Thompson, David
VALUE IN HEALTH, 2021, 24 (01) : 112 - 115
[46] Comparing Randomized Controlled Trials and Real-World Studies in Chronic Obstructive Pulmonary Disease Pharmacotherapy
Tashkin, Donald P.
Amin, Alpesh N.
Kerwin, Edward M.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 15 : 1225 - 1243
[47] Assessing the use of observational methods and real-world data to emulate ongoing randomized controlled trials
Wallach, Joshua D.
Deng, Yihong
Polley, Eric C.
Dhruva, Sanket S.
Herrin, Jeph
Quinto, Kenneth
Gandotra, Charu
Crown, William
Noseworthy, Peter
Yao, Xiaoxi
Jeffery, Molly Moore
Lyon, Timothy D.
Ross, Joseph S.
McCoy, Rozalina G.
CLINICAL TRIALS, 2023, 20 (06) : 689 - 698
[48] Intention-to-treat analysis in partially nested randomized controlled trials with real-world complexity
Schweig, Jonathan David
Pane, John F.
INTERNATIONAL JOURNAL OF RESEARCH & METHOD IN EDUCATION, 2016, 39 (03) : 268 - 286
[49] Clear Improvement in Real-World Chronic Myeloid Leukemia Survival: A Comparison With Randomized Controlled Trials
Vener, Claudia
Rossi, Silvia
Minicozzi, Pamela
Marcos-Gragera, Rafael
Poirel, Helene A.
Maynadie, Marc
Troussard, Xavier
Pravettoni, Gabriella
De Angelis, Roberta
Sant, Milena
FRONTIERS IN ONCOLOGY, 2022, 12
[50] Randomized controlled trials do not reflect reality: Real-world analyses are critical for treatment guidelines!
Grapow, MTR
von Wattenwyl, R
Guller, U
Beyersdorf, F
Zerkowski, HR
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2006, 132 (01): : 5 - 7

← 1 2 3 4 5 →